Current location:Culture Clutch news portal > opinions
Chinese inhibitor drug candidate becomes first to enter phase
Culture Clutch news portal2024-05-21 22:16:09【opinions】4People have gathered around
IntroductionChinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chines
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
Address of this article:http://timor-leste.claboston.org/html-93b199828.html
Very good!(92)
Related articles
- David Ortiz is humbled by being honored in New York again; this time for post
- Chinese diplomat calls for enhancing China
- Mascherano confirms Messi Olympics talks
- Beijing Central Axis: an exhibition of architectual beauty and a joy to behold at all times
- Macron is making a surprise trip to New Caledonia amid deadly unrest and indigenous frustration
- Int'l travel expo kicks off in Macao
- Chinese pickle spices up export hopes with Mexico
- Armed men kidnap a senior judge in Pakistan’s restive northwest
- Who is Abi Carter? Inside the American Idol winner's unconventional family life
- China prepares to launch Chang'e
Popular articles
Recommended
How Robert F. Kennedy Jr. could make the first debate stage
Mascherano confirms Messi Olympics talks
China adopts law on customs duties
Donald Trump is running against Joe Biden. But he keeps bringing up another Democrat: Jimmy Carter
Forensic psychiatrist reveals the different types of stalkers
Beijing Central Axis: an exhibition of architectual beauty and a joy to behold at all times
Donald Trump is running against Joe Biden. But he keeps bringing up another Democrat: Jimmy Carter
Humanitarian crisis in Gaza exposes Western double standard on human rights
Links
- Now THAT'S a holiday photo album: Couple who sold everything they own to travel share 15 jaw
- Pioneer women surfers reflect on their struggle for recognition
- Sagging bridge ‘warning shot’ work needed
- On Your Side: Survey reveals many college students carry credit
- Several arrested after brawl breaks out near Auckland harbour
- Changes to Gloriavale response could risk gains
- Motatau students make a splash with their underwater robotics
- Gaza aid agency 'extremely desperate' after funding halted
- Man hanging rainbow flag outside Destiny Church reportedly assaulted
- Farmers selling stock, land as 'extreme' drought dries up streams